tm logo
HER2DX
Live/Registered
REGISTERED

on 29 Nov 2022

Last Applicant/ Owned by

E-08036 Barcelona

ES

Serial Number

79312395 filed on 19th Mar 2021

Registration Number

6908909 registered on 29th Nov 2022

in the Principal Register

Correspondent Address

Donna A. Tobin

ROYER COOPER COHEN BRAUNFELD LLP

1120 Avenue of the Americas

4th Floor

New York, NY, 10036

Filing Basis

No Filing Basis

Disclaimer

NO DATA

HER2DX

Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistry, clinical chemistry and microbiology HER TO DX; HERRead More

Classification Information


Class [001]
Chemical Products


Diagnostic preparations for scientific use; reagents for research purposes; reagents for medical research purposes; diagnostic reagents for scientific use or for research use; reagents for scientific use or for research use in the field of cancer; diagnostic reagents for clinical or medical laboratory use in the field of in vitro in biochemistry, clinical chemistry and microbiology

Class [005]
Pharmaceutical Products


Products for medical diagnostics, namely, medical diagnostic reagents, medical diagnostic assays for testing body fluids and tissue, and specimen collection kits comprised of swabs for medical purposes and plastic bags for transmitting medical specimens, all for use in cancer detection; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; medical reagents for clinical use; medical diagnostic reagents for the analysis of body fluids and tissue; diagnostic reagents for use in diagnostic testing for medical purposes; diagnostic biomarker reagents for cancer diagnosis, prognosis and treatment for medical purposes; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of body fluids and tissue, and diagnostic reagents for medical use, all for cancer diagnosis, prognosis and treatment; pharmaceutical products for the treatment of cancer; biological preparations for cancer treatment; biopharmaceutical preparations for cancer treatment; pharmaceutical preparations for the treatment of cancer for oncological use; biological reagents, namely, clinical medical reagents; diagnostic reagent kits consisting primarily of diagnostic reagents for medical use, in the field of cancer

Mark Details


Serial Number

No 79312395

Mark Type

No Service/Collective Mark

Attorney Docket Number

No HER2DX

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Apr 2023FINAL DECISION TRANSACTION PROCESSED BY IB
17th Mar 2023FINAL DISPOSITION PROCESSED
17th Mar 2023FINAL DISPOSITION NOTICE SENT TO IB
28th Feb 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29th Nov 2022REGISTERED-PRINCIPAL REGISTER
29th Nov 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
27th Nov 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09th Nov 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09th Nov 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03rd Oct 2022NOTIFICATION PROCESSED BY IB